NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 56.70

+5.0%

Nov 14 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Saulamanca who wrote (183)	12/7/2006 12:24:12 PM
From: tuck	of 507

Alkermes product not likely until late '09 at earliest: Snip from today's update from Lilly: >> AIR® Inhaled Insulin - Enrollment has been completed in a critical, two-year safety trial, and other studies are ongoing for both the inhaled insulin formulation and device. Lilly and its partner, Alkermes, Inc., currently expect regulatory submission to the FDA in 2009.<< Alkermes is off even more than AMLN today, in per cent terms. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next